Compare EVO & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | USAS |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | Germany | Canada |
| Employees | 4766 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 821.2M | 3.2B |
| IPO Year | N/A | 2004 |
| Metric | EVO | USAS |
|---|---|---|
| Price | $2.42 | $7.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $7.00 | $4.08 |
| AVG Volume (30 Days) | 105.5K | ★ 5.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $26.21 |
| Revenue Next Year | $7.13 | $129.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $0.40 |
| 52 Week High | $4.80 | $10.50 |
| Indicator | EVO | USAS |
|---|---|---|
| Relative Strength Index (RSI) | 27.25 | 42.59 |
| Support Level | N/A | $6.67 |
| Resistance Level | $3.78 | $8.66 |
| Average True Range (ATR) | 0.10 | 0.62 |
| MACD | -0.10 | -0.24 |
| Stochastic Oscillator | 8.81 | 7.52 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.